LIU Qiongqiong,PANG Ran,CHEN Yueying,et al.Differentiation and Treatment of Interstitial Cystitis/Bladder Pain Syndrome Based on the Theory of Sores and Ulcers[J].Journal of Traditional Chinese Medicine,2024,65(16):1712-1716.
LIU Qiongqiong,PANG Ran,CHEN Yueying,et al.Differentiation and Treatment of Interstitial Cystitis/Bladder Pain Syndrome Based on the Theory of Sores and Ulcers[J].Journal of Traditional Chinese Medicine,2024,65(16):1712-1716.DOI: 10.13288/j.11-2166/r.2024.16.014.
Differentiation and Treatment of Interstitial Cystitis/Bladder Pain Syndrome Based on the Theory of Sores and Ulcers
It is believed that the endoscopic manifestations of interstitial cystitis/bladder pain syndrome (IC/BPS) such as extensive bleeding and Hunner's ulcers as well as its recurrent and prolonged condition are in line with the characteristics of sores and ulcers in traditional Chinese medicine (TCM), and the treatment can be referred to TCM theory of sores and ulcers. The mechanism of IC/BPS is c
haracterized by root deficiency and branch excess. The root cause is deficiency of the spleen and kidney
qi
, while the manifesting factors are dampness-heat and blood stasis. The treatment is based on the principles of promoting and supplementing, combining with resolving therapy, so that the symptoms could be relieved by promoting blood circulation and clearing heat, unblocking the collaterals and relieve pain. In clinical practice, modified
Neituo Shengji Powder
(内托生肌散) was commonly used to boost
qi
and invigorate blood, expel swollen sore and express toxin; combining with
Sijunzi Decoction
(四君子汤) or
Suoquan Pill
(缩泉丸) based on specific symptoms to strengthen the spleen and kidneys, thereby reinforcing healthy
qi
; according to concurrent symptoms like blood stasis, dampness heat, prescription with Sanleng (
Cyperus rotundus
), Ezhu (
Curcuma aromatica Salisb
) to invigorate blood and dissolve stasis, or Yiyiren (
Coix lacryma
-
jobi
), Zexie (
Alisma plantago
-
aquatica
) to clear heat and drain dampness.
关键词
Keywords
references
HANNO P . Diagnosis and treatment of interstitial cystitis/bladder pain syndrome [J]. J Urol , 2022 , 208 ( 6 ): 1178 .
CLEMENS JQ , ERICKSON DR , VARELA NP , et al . Diagnosis and treatment of interstitial cystitis/bladder pain syndrome [J]. J Urol , 2022 , 208 ( 1 ): 34 - 42 .
DRISCOLL A , TEICHMAN JM . How do patients with interstitial cystitis present? [J]. J Urol , 2001 , 166 ( 6 ): 2118 - 2120 .
MCKERNAN LC , WALSH CG , REYNOLDS WS , et al . Psychosocial co-morbidities in interstitial cystitis/bladder pain syndrome (IC/BPS): a systematic review [J]. Neurourol Urodyn , 2018 , 37 ( 3 ): 926 - 941 .
CHEN A , SHAHIYAN RH , ANGER JT . Interstitial cystitis/bladder pain syndrome treatment: a systematic review of sexual health outcomes [J]. Sex Med Rev , 2022 , 10 ( 1 ): 71 - 76 .
CHEN L , DENG H , CUI H , et al . Inflammatory responses and inflammation-associated diseases in organs [J]. Oncotarget , 2017 , 9 ( 6 ): 7204 - 7218 .
HOMMA Y , AKIYAMA Y , TOMOE H , et al . Clinical guidelines for interstitial cystitis/bladder pain syndrome [J]. Int J Urol , 2020 , 27 ( 7 ): 578 - 589 .
WHITMORE KE , FALL M , SENGIKU A , et al . Hunner lesion versus non-Hunner lesion interstitial cystitis/bladder pain syndrome [J]. Int J Urol , 2019 , 26 ( Suppl 1 ): 26 - 34 .
AKIYAMA Y , NIIMI A , NOMIYA A , et al . Efficacy and safety of intravesical dimethyl sulfoxide treatment for patients with refractory Hunner-type interstitial cystitis: real-world data postofficial approval in Japan [J]. Int J Urol , 2024 , 31 ( 2 ): 111 - 118 .
FALL M , NORDLING J , CERVIGNI M , et al . Hunner lesion disease differs in diagnosis, treatment and outcome from bladder pain syndrome: an ESSIC working group report [J]. Scand J Urol , 2020 , 54 ( 2 ): 91 - 98 .
CARDOZO L , ROVNER E , WAGG A , et al . Incontinence [M]. 7th Edition . Bristol UK : International Continence Society , 2023 : 1861 .